Adarza BioSystems Closes on $17 Million Series C Financing
Adarza BioSystems Closes on $17 Million Series C Financing
in
Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, Mo. manufacturing facility and fund final